Preclinical Characterization of Mitochondria-Targeted Small Molecule Hsp90 Inhibitors, Gamitrinibs, in Advanced Prostate Cancer

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-1818
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Investigation of TRPM4 in Prostate Cancer Cells With Novel Small Molecule Inhibitors

Biophysical Journal
Biophysics
2019English

Small-Molecule Inhibitors of the Receptor Tyrosine Kinases: Promising Tools for Targeted Cancer Therapies

International Journal of Molecular Sciences
Organic ChemistryMolecular BiologyTheoretical ChemistryInorganic ChemistryComputer Science ApplicationsSpectroscopyMedicineCatalysisPhysical
2014English

Discovery and Characterization of Small Molecule Rac1 Inhibitors

Oncotarget
Oncology
2017English

Small Molecule Tyrosine Kinase Inhibitors in Pancreatic Cancer

Biologics: Targets and Therapy
OncologyImmunologyGastroenterologyPharmacologyRheumatologyAllergy
2008English

Synthetic Lethality as a Targeted Approach to Advanced Prostate Cancer

2012English

Prostate Cancer Stem Cells: Molecular Characterization for Targeted Therapy

Asian Journal of Andrology
MedicineUrology
2012English

Immune Checkpoint Inhibitors in Advanced Non-Small Cell Lung Cancer

Cancer
Cancer ResearchOncology
2017English

Preclinical Efficacy of a PSMA-targeted Thorium-227 Conjugate (PSMA-TTC), a Targeted Alpha Therapy for Prostate Cancer

Clinical Cancer Research
Cancer ResearchOncology
2019English

Thailandepsins Are New Small Molecule Class I HDAC Inhibitors With Potent Cytotoxic Activity in Ovarian Cancer Cells: A Preclinical Study of Epigenetic Ovarian Cancer Therapy

Journal of Ovarian Research
GynecologyOncologyObstetrics
2012English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy